2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 17- Coagulation and Thrombosis II (Xeno Track)

36.504 - Activated protein C levels generated by GalT-KO PAEC expressing human endothelial protein C receptor and thrombomodulin in the early stage of interaction with human protein C and thrombin

Presenter: Cristiana, Bulato, Padova, Italy
Authors: Cristiana Bulato1, Claudia Maria Radu1, Sabrina Gavasso1, Cesare Galli2, Andrea Perota2, Federica Besenzon3, Emanuele Cozzi3, Paolo Simioni1

504

Activated protein C levels generated by GalT-KO PAEC expressing human endothelial protein C receptor and thrombomodulin in the early stage of interaction with human protein C and thrombin

Cristiana Bulato1, Claudia Maria Radu1, Sabrina Gavasso1, Cesare Galli2, Andrea Perota2, Federica Besenzon3, Emanuele Cozzi3, Paolo Simioni1

1Department of Cardiologic, Thoracic and Vascular Sciences, University of Padua, Padua; 2Laboratorio di Tecnologie della Riproduzione, Avantea, Cremona; 3Consortium for Research on Organ Transplantation, CORIT, Padua; Italy

 

Introduction: Kidneys from GalT-KO pigs are rejected when transplanted into primates, due to the formation of thrombi in the microvasculature. Thrombosis could be prevented by the co-expression on vascular endothelium of these transgenic pigs of two human anticoagulant proteins, endothelial protein C receptor (EPCR) and thrombomodulin (TM), which are involved in the activation of protein C (PC).

Aim of the study: We have already demonstrated that GalT-KO PAEC, expressing both human EPCR and TM, activate human PC more efficiently than PAEC expressing only one receptor. This result is observed after incubation of cells with human PC and thrombin for long periods (1 to 4 hours). Aim of the research is to determine the levels of human activated PC (APC) produced at the beginning of the reaction.

Methods: The activation PC assay was performed in the following cell lines: Human Coronary Artery Endothelial Cells (HCAEC), GalT-KO PAEC expressing hEPCR or hTM and GalT-KO PAEC expressing both human receptors. Human PC and thrombin were added to confluent cells and APC formed was measured by a chromogenic substrate after 10, 20 and 30 min of incubation.

Results: hEPCR-GalT-KO PAEC did not activate human PC. The APC generated by hTM-GalT-KO PAEC, after exposure to human PC and thrombin for 10, 20 and 30 min, was 0.57±0.01 ug/ml, 1.47±0.01 ug/ml and 3.40±0.02 ug/ml, respectively. The APC level detected in hEPCR-hTM-GalT-KO PAEC after 10, 20 and 30 min was 6.06±0.01 ug/ml, 10.49±0.07 ug/ml and 13.36±0.17 ug/ml, respectively. Finally, the APC produced by our human cell line at 10, 20 and 30 min was 0.69±0.02 ug/ml, 1.45±0.01 ug/ml and 2.53±0.02 ug/ml, respectively.

Conclusions: The co-expression of both human EPCR and TM on GalT-KO PAEC is required to obtain the optimal activation of human PC, even during the early stage of interaction of pig cell surface with human PC and thrombin.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada